Synthesis and cellular compatibility of biomineralized Fe3O4 nanoparticles in tumor cells targeting peptides

Colloids and Surfaces B: Biointerfaces

Volumn 107, Issue , 2013, Pages 180-188

  Wei, Yan ^a   Yin, Guangfu ^a   Ma, Chuying ^a   Huang, Zhongbing ^a   Chen, Xianchun ^a   Liao, Xiaoming ^a   Yao, Yadong ^a   Yin, Hao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Biomineralization; Cancer targeting; Magnetic property; WSG peptide

Indexed keywords

BIOMINERALIZATION; BIOSYNTHESIS; DIAGNOSIS; DISEASES; NANOMAGNETICS; NANOPARTICLES; PEPTIDES; SATURATION MAGNETIZATION;

CANCER CELLS; CANCER-TARGETING; CELL TARGETING; CELL VIABILITY ASSAYS; CELLULAR COMPATIBILITY; MIXING TIME; PROPERTY; TARGETING PEPTIDES; TUMOUR CELLS; WSG-PEPTIDE;

MAGNETITE;

MAGNETITE NANOPARTICLE; PEPTIDE; TRYPTOPHYLSERYLGLYCYLPROPYLGLYCYLVALYLTRYPTOPHYLGLYCYLALANYLSERYLVALYLLYSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BIOMAGNETISM; BIOMINERALIZATION; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MATERIAL COATING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; ROOM TEMPERATURE; STRUCTURE ANALYSIS; TUMOR CELL;

EID: 84875075026     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.01.058     Document Type: Article

References (53)

1. Kumar A., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995.
2. Nitin N., LaConte L.E., Zurkiya O., Hu X., Bao G. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J. Biol. Inorg. Chem. 2004, 9:706.
3. Huh Y.-M., Jun Y.-W., Song H.-T., Kim S., Choi J.-S., Lee J.-H., Yoon S., Kim K.-S., Shin J.-S. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. JACS 2005, 127:12387.
4. Sun C., Lee J.S.H., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliver. Rev. 2008, 60:1252.
5. Jun Y.-W., Huh Y.-M., Choi J.-S., Lee J.-H., Song H.-T., Kim S., Yoon S., Kim K.-S., Shin J.-S., Suh J.-S., Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. JACS Commun. 2005, 127:5732.
6. Lee H.Y., Li Z., Chen K., Hsu A.R., Xu C., Xie J., Sun S., Chen X. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med.: Off. Public. Soc. Nucl. Med. 2008, 49:1371.
7. Street C., Street G. Recent development for synthesis of magnetic nanoparticles for biomedical applications. Int. J. Nanosci. 2011, 10:883.
8. Tartaj P., Morales P., Veintemillas-verdaguer S., Gonz T. The preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys. 2003, 36:R182.
9. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliver. Rev. 2008, 60:1241.
10. Gao J., Gu H., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc. Chem. Res. 2009, 42:1097.
11. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel Kj{cyrillic}.A.E., Tamanoi F., Zink J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889.
12. Laurent S., Forge D., Port M., Roch A., Robic C., Elst L.V., Muller R.N. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108:2064.
13. Pan Y., Du X., Zhao F., Xu B. Magnetic nanoparticles for the manipulation of proteins and cells. Chem. Soc. Rev. 2012, 41:2912.
14. Gu H., Xu K., Xu B. Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem. Commun. 2006, 9:941.
15. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., Bruinink A., Stark W.J. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 2006, 40:4374.
16. Auffan M., Decome L., Rose J., Orsiere T., De Meo M., Briois V., Chaneac C., Olivi L., Berge-Lefranc J.L., Botta A., Wiesner M.R., Bottero J.Y. In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: a physicochemical and cyto-genotoxical study. Environ. Sci. Technol. 2006, 40:4367.
17. 4) nanoparticles and their drug conjugate. RSC Adv. 2012, 2:2493.
18. Berry C.C., Wells S., Charles S., Curtis A.S. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003, 24:4551.
19. Gupta A.K., Curtis A.S. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med. 2004, 15:493.
20. (4)@Au composite magnetic nanoparticles in vitro and in vivo. Int. J. Nanomed. 2011, 6:2805.
21. Zhang S., Chen X., Gu C., Zhang Y., Xu J., Bian Z., Yang D., Gu N. The effect of iron oxide magnetic nanoparticles on smooth muscle cells. Nanoscale Res. Lett. 2009, 4:70.
22. Wu X., Tan Y., Mao H., Zhang M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int. J. Nanomed. 2010, 5:385.
23. Yu M., Huang S., Yu K.J., Clyne A.M. Dextran and polymer polyethylene glycol (peg) coating reduce both 5 and 30nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 2012, 13:5554.
24. 4 magnetic nanoparticles used in tumor hyperthermia. 1st IEEE International Conference on NEMS '06 2006, 339.
25. 4 nanoparticles: an in vitro study. J. Nanomater. 2012, 2012:1.
26. (4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 2010, 21:75102.
27. Chatterjee D.K., Diagaradjane P., Krishnan S. Nanoparticle-mediated hyperthermia in cancer therapy. Therap. Deliver. 2011, 2:1001.
28. (4) nanoparticles and their cytotoxic effect on MCF-7 cells. Int. J. Nanomed. 2012, 7:4973.
29. Wei K., Xu X., Pu X., Hou Z., Zhang Q. Cytotoxic effects and the mechanism of three types of magnetic nanoparticles on human hepatoma BEL-7402 cells. Nanoscale Res. Lett. 2011, 6:480.
30. Li Y., Chen Z., Li F., Wang J., Zhang Z. Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma. Int. J. Nanomed. 2012, 7:4593.
31. Nazli C., Ergenc T.I., Yar Y., Acar H.Y., Kizilel S. RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells. Int. J. Nanomed. 2012, 7:1903.
32. Tomitaka A., Hirukawa A., Yamada T., Morishita S., Takemura Y. Biocompatibility of various ferrite nanoparticles evaluated by in vitro cytotoxicity assays using HeLa cells. J. Magn. Magn. Mater. 2009, 321:1482.
33. 4 magnetite nanoparticles and their cytotoxicity on 4 T1 breast cancer cells. DARU J. Pharm. Sci. 2012, 20:1.
34. Ying E., Hwang H.M. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci. Total Environ. 2010, 408:4475.
35. Pisanic T.R., Blackwell J.D., Shubayev V.I., Finones R.R., Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28:2572.
36. Mout R., Moyano D.F., Rana S., Rotello V.M. Surface functionalization of nanoparticles for nanomedicine. Chem. Soc. Rev. 2012, 41:2539.
37. Cavalli S., Carbajo D., Acosta M., Lope-piedrafita S., Albericio F., Candiota A.P., Aru C. Efficient c-amino-proline-derived cell penetrating peptide - superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagentsw. Chem. Comm. 2012, 48:5322.
38. Berry C.C. Intracellular delivery of nanoparticles via the HIV-1 tat peptide. Nanomedicine 2008, 3:357.
39. Morales-avila E., Ferro-flores G., Ocampo-garcía B.E., Le L.M.D., Santos-cuevas C.L., García-becerra R., Medina L.A. Multimeric system of 99m Tc-labeled gold nanoparticles conjugated to c [RGDfK (C)] for molecular imaging of tumor r (v) β (3) expression. Bioconjugate Chem. 2011, 22:913.
40. Naik B.R.R., Jones S.E., Murray C.J., McAuliffe J.C., Vaia R.A., Stone M.O. Peptide templates for nanoparticle synthesis derived from polymerase chain reaction-driven phage display. Adv. Funct. Mater. 2004, 14:25.
41. Proteins T.A., Monolayers P.S.A. Peptide-capped gold nanoparticles: towards artificial proteins. ChemBioChem 2006, 7:1141.
42. Kogan M.J., Olmedo I., Hosta L. Peptides and metallic nanoparticles for biomedical applications. Small 2007, 2:287.
43. Search H., Journals C., Contact A., Iopscience M., Address I.P. Peptides as capping ligands for in situ synthesis of water soluble Co nanoparticles for bioapplications. Physics 2005, 17:70.
44. Li J., Huang Z., Wu D., Yin G., Liao X., Gu J. Preparation and protein detection of Zn-ferrite film with magnetic and photoluminescence properties. J. Phys. Chem. C 2009, 114:1586.
45. Hussain I., Nichols R.J., Schiffrin D.J., Brust M., Fernig D.G. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. JACS 2004, 126:10076.
46. 4 nanoparticles. Biomaterials 2005, 26:2749.
47. 4 nanoparticles and sulfonated polyanilines. J. Appl. Polym. Sci. 2007, 104:4127.
48. Lee S.-J., Jeong J.-R., Shin S.-C., Kim J.-C., Chang Y.-H., Chang Y.-M., Kim J.-D. Nanoparticles of magnetic ferric oxides encapsulated with poly (d, l latide-co-glycolide) and their applications to magnetic resonance imaging contrast agent. J. Magn. Magn. Mater. 2004, 276:2432.
49. Yan D., Yin G., Huang Z., Liao X., Kang Y., Yao Y., Hao B., Gu J., Han D. Biomineralization of uniform gallium oxide rods with cellular compatibility. Inorg. Chem. 2009, 48:6471.
50. Zou Y., Huang Z., Wang Y., Liao X., Yin G., Gu J. Synthesis and cellular compatibility of Co-doped ZnO particles in silk-fibroin peptides. Colloid. Surf. B: Biointerf. 2012, 102:29.
51. Pieters R., Loonen A.H., Huismans D.R., Broekema G.J., Dirven M.W., Heyenbrok M.W., Hahlen K., Veerman A.J. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 1990, 76:2327.
52. Auffan M., Achouak W., Rose J., Roncato M.A., Chaneac C., Waite D.T., Masion A., Woicik J.C., Wiesner M.R., Bottero J.Y. Relation between the redox state of iron-based nanoparticles and their cytotoxicity toward Escherichia coli. Environ. Sci. Technol. 2008, 42:6730.
53. Geppert M., Hohnholt M.C., Nurnberger S., Dringen R. Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater. 2012, 8:3832.